ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

VAL Valirx Plc

3.35
0.05 (1.52%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Valirx Plc LSE:VAL London Ordinary Share GB00BLH13C52 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.05 1.52% 3.35 3.30 3.40 3.35 3.30 3.30 164,059 15:18:31
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Medical Laboratories 0 -2.37M -0.0262 -1.28 3.02M
Valirx Plc is listed in the Medical Laboratories sector of the London Stock Exchange with ticker VAL. The last closing price for Valirx was 3.30p. Over the last year, Valirx shares have traded in a share price range of 3.25p to 14.75p.

Valirx currently has 90,174,156 shares in issue. The market capitalisation of Valirx is £3.02 million. Valirx has a price to earnings ratio (PE ratio) of -1.28.

Valirx Share Discussion Threads

Showing 24126 to 24147 of 29350 messages
Chat Pages: Latest  970  969  968  967  966  965  964  963  962  961  960  959  Older
DateSubjectAuthorDiscuss
17/3/2022
20:57
In the bio world, things take time and often overrun. If you use this philosophy rather than looking at hard and fast rules and timescales you could relax and accept that 201 is in very capable hands and is a excellent IP. GLA
wulber
17/3/2022
20:54
Porky, the end of December was never a deadline but an imaginary deadline dreamt up by posters.The end of March is also not a deadline, but an anticipated guide based on giving THX room to process funding which is time consuming and involves lots of red tape and hoops to jump through.
wulber
17/3/2022
11:35
Porky , give it a rest. Everyone can see you are a clown
3put
17/3/2022
11:28
The simple fact there’s no stock around under 30p says to me we hit that at some point later on today.
And all without the coming news.

412069
17/3/2022
08:43
He’s getting whacked on DDDD poor thing.
412069
17/3/2022
08:37
Porky - wouldn’t trust you as far as I could throw you.

You said on LSE approx 7 days ago you would not post there again until the 31/3 or a deal finalised but you couldn’t help yourself and we’re back posting there again within a day or two.

Just do one please. You have very little to offer here. Enjoy your losses in the other shares you own.

francoismyname
17/3/2022
08:09
Maybe back on the % leader board again today with volume.
412069
17/3/2022
08:09
Maybe back on the % leader board again today with volume.
412069
17/3/2022
03:05
The fact remains that the end of December deadline was missed, and the long stop date is less than two weeks away and let’s face it this confirmation is business critical.

Now the CEO has given the strongest possible indication that the deal is done and its now a formality and confirmation is imminent. Even yesterday that still remained the case. So much so that I commented on both Twitter and LSE that the update was indeed going to land despite me being possibly one of the harshest critics of the arrangements for 201.

Unofficially, based on what was intimated, I was expecting the RNS yesterday if not today at open. Officially (RNS 5/1/22) the statement confirms “by end-Q1 2022” so they have an obligation to update the market on or before market close on Thursday 31st March either way if they need to take it right to the wire.

Personally, I see no reason why the confirmation won’t land but it would be wrong to insinuate that it is guaranteed when the official notices from the company state otherwise.

Finally, the presentation and Q&A scheduled for 6th April relates to the Operational and Strategy Update. I am specifically interested in this presentation as I am hoping for clarity on how the prospective integrated services entity fits in with the revised business and forward plans. As a shareholder I have a vested interested in this business continuing to be a success.

Let’s see how events unfold, based on Wednesday’s buying activity there is clearly confidence in a positive outcome.

GLA

porky9
16/3/2022
13:35
Just need to break the 200 dma at about 28p and technically it should hopefully break upwards back to the 30's - fingers crossed!
wulber
16/3/2022
13:21
Darkhero - it was mentioned in the original RNS last year " Completion of the Licence Agreement is subject to, inter alia, the successful fundraise by TheoremRx."
idomeneo
16/3/2022
12:04
plenty arab! That's how I can spot one!
chesty1
16/3/2022
12:03
Do you hold any other dogs chesty ? Lol
arab3
16/3/2022
12:02
What before the news…. You f ing mad or do you just like losing money.
412069
16/3/2022
11:59
Anything above 27p dump this dog!
chesty1
16/3/2022
10:34
30p min thus week pre news then 70p on news.
412069
16/3/2022
07:19
Interesting RNS from Val yesterday. TheromemRX deal conditional on fund raise completion. Strange how Nick Slater has been silent on this when asked if he has any news on this especially considering his close connection to Mark Treharne.... Inside information maybe? 100 guarantee deal has been delayed.
darkhero1981
15/3/2022
12:08
Finals due by end of April ( usually) & all will be clarified by then
base7
15/3/2022
11:11
Yes £6m.
412069
15/3/2022
10:59
I see PYC is moving up.I wonder if there is a connection.
sean cadman
15/3/2022
10:54
I'm seeing us at 25p + come the close today, no stock for sale around this share price
412069
15/3/2022
09:04
Do any of your dreams come true 36jay ?
arab3
Chat Pages: Latest  970  969  968  967  966  965  964  963  962  961  960  959  Older

Your Recent History

Delayed Upgrade Clock